GNAS and urinary bladder carcinoma: T393C polymorphism in the gene GNAS1 was significantly associated with favorable clinical outcome of patients suffering from bladder cancer, chronic lymphocytic leukemia [15], and renal cell carcinoma [16], and significantly associated with unfavorable clinical outcome of patients suffering from ICC and breast cancer [13, 14].